NCT07469891 2026-03-13
A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms
Prelude Therapeutics
Phase 1 Not yet recruiting
Prelude Therapeutics
Grupo Español de Enfermedades Mieloproliferativas Crónicas PH Negativas
Washington University School of Medicine
Brigham and Women's Hospital
Stanford University